Background: Peripheral nerve injury (PNI) repair is a challenging task, resulting usually in unsatisfactory outcomes. (1,2) Rat epineural sheath conduit supported with rat bone marrow-derived stromal cells demonstrated neuroregenerative potential by providing neuroprotection, neovascularisation, and secretion of neurotrophic factors.(3-5) To bring this approach to clinical applications, we developed a new biologic construct for nerve regeneration -human epineural conduit (hEC) consisting of human epineural sheath (hES) filled with human mesenchymal stem cells (hMSC). The aim of this study was to assess the feasibility of hEC on the PNI repair in the nude rat model.
. Preparation of human epineural sheath (hEC) conduit. A-Normal human cadaver median nerve, BFascicles removed from human cadaver median nerve, C -pre-fabricated human median nerve epineural sheath conduit. (human epineural conduit -hEC) created by surgical removal (counter pressure technique) of nerve fascicles from human median nerve under operating (40X) microscope.
Results: Cultured hMSC expressed CD105, CD73 and CD90. Proangiogenic factor VEGF and neurogenic factor laminin B were strongly expressed on the surface of hES ( Figure 2 ). No leakage of cells was observed at the time of injection during conduit implantation. hEC maintained its shape and integrity at 12 weeks following repair. No local inflammation or scarring was observed at the end of the follow up. Clinical evaluation and SSEP analysis confirmed sciatic nerve recovery in groups 3 and 4 with outcomes comparable to nerve autograft repair. Immunostaining showed presence of the hMSC in the conduit at 12 weeks post-implantation. Quantitative nerve and muscle histological analysis is currently in progress. 
Conclusion:
This study confirmed the feasibility of the application of hEC for restoration of PNI. The functional outcomes following the use of hEC were comparable to the golden standard of autograft repair. hEC is a promising new technology for regeneration of long gap nerve defects which combines the effect of neurotropic properties of hES and immunomodulating properties of hMSC.
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